New options with dabigatran etexilate in anticoagulant therapy

References

• GeertsWHBergqvistDPineoGFPrevention of Venous Thromboembolism: American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008381S453S18574271
   PubMedGoogle Scholar
• MollSMackmanNVenous thromboembolism: a need for more public awareness and research into mechanismsArterioscler Thromb Vasc Biol20082836736918296590
   PubMed Web of Science ®Google Scholar
• CohenATTapsonVFBergmannJFENDORSE InvestigatorsVenous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional studyLancet200837138739418242412
   PubMed Web of Science ®Google Scholar
• LapostolleFSurgetVBorronSWSevere pulmonary embolism associated with air travelN Engl J Med200134577978311556296
   PubMed Web of Science ®Google Scholar
• FrancisCWClinical practice. Prophylaxis for thromboembolism in hospitalized medical patientsN Engl J Med20073561438144417409325
   PubMed Web of Science ®Google Scholar
• HeitJASilversteinMDMohrDNPettersonTMO’FallonWMMeltonLJ3rdRisk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control studyArch Intern Med200016080981510737280
   PubMed Web of Science ®Google Scholar
• WhiteRHThe epidemiology of venous thromboembolismCirculation2003107I4I812814979
   PubMed Web of Science ®Google Scholar
• KearonCNatural history of venous thromboembolismCirculation2003107I22I3012814982
   PubMed Web of Science ®Google Scholar
• RodgerMAKahnSRWellsPSIdentifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyCMAJ200817941742618725614
   PubMed Web of Science ®Google Scholar
• KahnSRThe post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosisJ Thromb Thrombolysis200621414816475040
   PubMed Web of Science ®Google Scholar
• HaenenJHJanssenMCvan LangenHThe postthrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and strain-gauge plethysmographyJ Vasc Surg1999291071107610359941
   PubMed Web of Science ®Google Scholar
• PrandoniPLensingAWCogoAThe long-term clinical course of acute deep venous thrombosisAnn Intern Med1996125178644983
   PubMed Web of Science ®Google Scholar
• PengoVLensingAWPrinsMHIncidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismN Engl J Med20043502257226415163775
   PubMed Web of Science ®Google Scholar
• FedulloPFAugerWRKerrKMRubinLJChronic thromboembolic pulmonary hypertensionN Engl J Med20013451465147211794196
   PubMed Web of Science ®Google Scholar
• SingerDEAlbersGWDalenJEAmerican College of Chest PhysiciansAntithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest200813354659218252921
   PubMed Web of Science ®Google Scholar
• LipGNieuwlaatRPistersRLaneDCrijnsHRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial FibrillationChest201013726327219762550
   PubMed Web of Science ®Google Scholar
• SchnabelRBSullivanLMLevyDDevelopment of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyLancet200937373974519249635
   PubMed Web of Science ®Google Scholar
• HylekEMAntithrombotic prophylaxis in elderly patients with atrial fibrillationSemin Thromb Hemost20093554855319787558
   PubMed Web of Science ®Google Scholar
• LeviMHobbsFDJacobsonAKImproving antithrombotic management in patients with atrial fibrillation: current status and perspectivesSemin Thromb Hemost20093552754219787556
   PubMed Web of Science ®Google Scholar
• PistersRde VosCBNieuwlaatRCrijnsHJUse and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigmsSemin Thromb Hemost20093555455919787559
   PubMed Web of Science ®Google Scholar
• LeviMde PeuterORKamphuisenPWManagement strategies for optimal control of anticoagulation in patients with atrial fibrillationSemin Thromb Hemost20093556056719787560
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEMAmerican College of CardiologyAmerican Heart Association Task Force on Practice GuidelinesACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol200750115717601538
   PubMed Web of Science ®Google Scholar
• VickreyBGRectorTSWickstromSLOccurrence of secondary ischemic events among persons with atherosclerotic vascular diseaseStroke20023390190611935034
   PubMed Web of Science ®Google Scholar
• CannegieterSCTornMRosendaalFROral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complicationsJ Intern Med199924536937410356599
   PubMed Web of Science ®Google Scholar
• American College of Cardiology/American Heart Association Task Force on Practice GuidelinesSociety of Cardiovascular AnesthesiologistsSociety for Cardiovascular Angiography and InterventionsSociety of Thoracic SurgeonsBonowROCarabelloBAKanuCACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation200611484231
   Web of Science ®Google Scholar
• VahanianABaumgartnerHBaxJTask Force on the Management of Valvular Hearth Disease of the European Society of CardiologyESC Committee for Practice GuidelinesGuidelines on the management of valvular heart diseaseEur Heart J20072823026817259184
   PubMed Web of Science ®Google Scholar
• HirshJGuyattGAlbersGWHarringtonRSchünemannHJAmerican College of Chest PhysicianAntithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008133110112
   PubMed Web of Science ®Google Scholar
• EikelboomJWWeitzJIA replacement for warfarin: the search continuesCirculation200711613113317576860
   PubMed Web of Science ®Google Scholar
• HirshJO’DonnellMEikelboomJWBeyond unfractionated heparin and warfarin: current and future advancesCirculation200711655256017664384
   PubMed Web of Science ®Google Scholar
• FrydmanALow-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humansHaemostasis19962624388707165
   PubMedGoogle Scholar
• BickRLFrenkelEPWalengaJFareedJHoppensteadtDAUnfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical useHematol Oncol Clin North Am20051915115639107
   PubMed Web of Science ®Google Scholar
• VeselyMRKelemenMDCardiac risk assessment: matching intensity of therapy to riskCardiol Clin200624677816326257
   PubMed Web of Science ®Google Scholar
• WarkentinTEGreinacherAKosterALincoffAMTreatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008340S380S18574270
   PubMed Web of Science ®Google Scholar
• ChaturvediVKarthikeyanGFondaparinux in acute coronary syndromesExpert Opin Drug Metab Toxicol200951615162319929450
   PubMed Web of Science ®Google Scholar
• HarenbergJWehlingMCurrent and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIaSemin Thromb Hemost200834395718393142
   PubMed Web of Science ®Google Scholar
• HaasSNew anticoagulants – towards the development of an “ideal” anticoagulantVasa200938132919229800
   PubMed Web of Science ®Google Scholar
• WienenWStassenJMPriepkeHRiesUJHauelNAntithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosisJ Thromb Haemost200751237124217362226
   PubMed Web of Science ®Google Scholar
• StangierJRathgenKStähleHGansserDRothWThe pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBr J Clin Pharmacol20076429230317506785
   PubMed Web of Science ®Google Scholar
• ErikssonBISmithHYasothanUKirkpatrickPDabigatran etexilateNat Rev Drug Discov2008755755818591978
   PubMed Web of Science ®Google Scholar
• HaasSNew oral Xa and IIa inhibitors: updates on clinical trial resultsJ Thromb Thrombolysis200825526017965837
   PubMed Web of Science ®Google Scholar
• WolowaczSERoskellNSPlumbJMEconomic evaluation of dabigatran etexilate for the preventionof venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacementThromb Haemost201010336037120024501
   PubMed Web of Science ®Google Scholar
• StangierJClemensAPharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitorClin Appl Thromb Hemost2009819 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• DahlOEDabigatran etexilate: A new oral thrombin inhibitortherapy20085111
   Google Scholar
• WienenWStassenJMPriepkeHRiesUJHauelNIn-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilateThromb Haemost20079815516217598008
   PubMed Web of Science ®Google Scholar
• ErikssonBIDahlOERosencherNRE-MODEL Study GroupOral dabigatran etexilate vs subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the REMODEL randomized trialJ thromb Haemost200752178218517764540
   PubMed Web of Science ®Google Scholar
• ErikssonBIDahlOERosencherNRE-NOVATE Study GroupDabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trialLancet200737094995617869635
   PubMed Web of Science ®Google Scholar
• GinsbergJSDavidsonBLCompPCRE-MOBILIZE Writing CommitteeOral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgeryJ Arthroplasty2009241918534438
   PubMed Web of Science ®Google Scholar
• FujiTFuijitaSUjihiraTSatoTDabigatran etexilate prevents venous thromboembolism after total knee arthroplasty in Japanese patients, with a safety profile comparable to placeboJ Arthroplasty20091024 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• SchulmanSKearonCKakkarAKDabigatran versus warfarin in the treatment of acute venous thromboembolismN Engl J Med20093612342235219966341
   PubMed Web of Science ®Google Scholar
• QureshiAIFeldmannEGomezCRIntracranial atherosclerotic disease: an updateAnn Neurol20096673073820035502
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med200714685786717577005
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA20012852864287011401607
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and Investigators. Dabigatran versus Warfarin in Patients with Atrial FibrillationN Engl J Med20093611139115119717844
   PubMed Web of Science ®Google Scholar
• GageBFCan we rely on RE-LY?N Engl J Med20093611200120219717843
   PubMed Web of Science ®Google Scholar
• HerijgersPVerhammePImproving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?Eur Heart J2007282424242617890728
   PubMed Web of Science ®Google Scholar
• Viles-GonzalezJFFusterVBadimonJJAtherothrombosis: a widespread disease with unpredictable and life-threatening consequencesEur Heart J2004251197120715246637
   PubMed Web of Science ®Google Scholar
• TurpieAGDirect Factor Xa and direct thrombin inhibitors: a clinical trial updateCurr Opin Drug Discov Devel200912497508
   PubMedGoogle Scholar
• HolmesDRJrKereiakesDJKleimanNSCombining antiplatelet and anticoagulant therapiesJ Am Coll Cardiol2009549510919573725
   PubMed Web of Science ®Google Scholar
• WeitzJIFactor Xa or thrombin: is thrombin a better target?J Thromb Haemost20075656717635711
   PubMedGoogle Scholar
• MackmanNTriggers, targets and treatments for thrombosisNature200845191491818288180
   PubMed Web of Science ®Google Scholar